Table 3.
Frequency of Location of LAP Based on the Type of Vaccine
| Vaccine Type | Location of LAP | Number (%) |
|---|---|---|
| Pfizer-BioNTech | Axillary | 29 (36.7) |
| Supraclavicular | 2 (2.5) | |
| Infraclavicular | 1 (1.2) | |
| Lateral neck | 1 (1.2) | |
| Moderna | Axillary | 17 (21.5) |
| Supraclavicular | 2 (2.5) | |
| Lateral neck | 1 (1.2) | |
| Subpectoral | 1 (1.2) | |
| Oxford-AstraZeneca | Axillary | 1 (1.2) |
| Total† | Axillary | 65 (82.3) |
| Supraclavicular | 9 (11.4) | |
| Infraclavicular | 1 (1.2) | |
| Neck and subpectoral | 4 (5.1) |
†
We included the LAP location of 20 cases who vaccine type was not reported or only reported as mRNA COVID-19 vaccine in the total section.